Related Experiment Video
Updated: May 1, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Autophagy genes variants and paediatric Crohn's disease phenotype: a single-centre experience
Caterina Strisciuglio1, Renata Auricchio1, Massimo Martinelli1
1Department of Translational Medical Sciences, Section of Pediatrics, University of Naples "Federico II", Italy.
Insights
Genetic variants in autophagy genes are linked to a more aggressive Crohn's disease course in children. Specifically, ATG16L1 variants correlate with increased relapses and earlier immunosuppressant use in pediatric Crohn's disease patients.
Area of Science:
- Genetics
- Pediatric Gastroenterology
- Immunology
Background:
- Limited evidence exists on single nucleotide polymorphisms (SNPs) and Crohn's disease (CD) phenotypes in children.
- Autophagy gene variants' association with pediatric CD clinical features remains under-investigated.
Purpose of the Study:
- To investigate the relationship between autophagy gene variants (ATG16L1, NOD2/CARD15, IRGM1) and clinical features in children with Crohn's disease.
Main Methods:
- Genotyping of ATG16L1, NOD2/CARD15, and IRGM1 in 80 pediatric CD patients.
- Classification of disease location and behavior using the Paris classification.
- Collection of demographic, clinical, and treatment data.
Main Results:
- Homozygosity for ATG16L1 (T300A) risk allele showed a trend towards a stricturing phenotype (p=0.01).
- ATG16L1 risk allele homozygosity correlated with increased relapses (p=0.006) and earlier immunosuppressant initiation (p=0.04).
- NOD2 rs2066847 heterozygosity was linked to major ileal involvement (p=0.01).
Conclusions:
- The T300A variant in ATG16L1 is associated with a more aggressive clinical course in pediatric Crohn's disease.
- Specific genetic variations influence disease behavior and treatment requirements in children with Crohn's disease.
Background And Aims:
Little evidence demonstrating the correlation between several single nucleotide polymorphisms and a specific phenotype of Crohn's disease has been reported in children. We investigated the relationship between autophagy genes variants and clinical features in our children with Crohn's disease.
Methods:
Genotyping for ATG16L1, NOD2/CARD15, and IRGM1 was performed in 80 consecutive patients with Crohn's disease (median age: 11 years; range: 0.7-17.9 years). Crohn's disease location and behaviour were classified using the Paris classification. Additional data were collected from clinical records on patients' demographics, age at symptom onset and diagnosis, extraintestinal manifestations, therapy, clinical relapses, and need of surgical intervention.
Results:
Patients homozygous for the risk allele ATG16L1 (T300A) showed a trend towards switching to a stricturing phenotype during the course of disease compared to children either homozygous for the wild-type allele or heterozygous for the ATG16L1 single nucleotide polymorphism (p=0.01). Homozygosity for the ATG16L1 risk allele was associated with a major recurrence of clinical relapses and earlier introduction of immunosuppressants (p=0.006 and p=0.04, respectively). Heterozygosity for the NOD2 rs2066847 allele was associated with major ileal involvement (p=0.01).
Conclusion:
In patients carrying the T300A variant, Crohn's disease follows a more aggressive clinical course.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Lysosomal Hydrolases
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Pharmacogenomics: Identification of New Drug Targets
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

